Cowen Starts Tandem Diabetes (TNDM) at Outperform
Tweet
Share
E-mailGet Alerts TNDM Hot Sheet
Price: $14.41 --0%
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 6 | New: 31
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 6 | New: 31
Join SI Premium – FREE
Cowen initiated coverage on Tandem Diabetes (NASDAQ: TNDM) with an Outperform rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Neutral Tandem click here. For more ratings news on Neutral Tandem click here.
Shares of Neutral Tandem closed at $13.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
- Barclays Starts SAB Biotherapeutics (SABS) at Overweight
- Leerink Starts Rapport Therapeutics (RAPP) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
